Literature DB >> 1693524

Denaturant-dependent folding of bovine pancreatic trypsin inhibitor mutants with two intact disulfide bonds.

M R Hurle1, C B Marks, P A Kosen, S Anderson, I D Kuntz.   

Abstract

The equilibrium and kinetic behavior of the guanidine hydrochloride (Gdn-HCl) induced unfolding/refolding of four bovine pancreatic trypsin inhibitor (BPTI) mutants was examined by using ultraviolet difference spectroscopy. In three of the mutants, we replaced the buried 30-51 disulfide bond with alanine at position 51 and valine (Val30/Ala51), alanine (Ala30/Ala51), or threonine (Thr30/Ala51) at position 30. For the fourth mutant, the solvent-exposed 14-38 disulfide was substituted by a pair of alanines (Ala14/Ala38). All mutants retained the 5-55 disulfide. Experiments were performed under oxidizing conditions; thus, both the unfolded and folded forms retained two native disulfide bonds. Equilibrium experiments demonstrated that all four mutants were destabilized relative to wild-type BPTI. However, the stability of the 30-51 mutants increased with the hydrophobicity of the residue substituted at position 30. Kinetic experiments showed that all four mutants contained two minor slow refolding phases with characteristics of proline isomerization. The specific behavior of the phases depended on the location of the disulfide bonds. The major unfolding/refolding phase for each of the 30-51 mutants was more than an order of magnitude slower than for Ala14/Ala38 or for BPTI in which the 14-38 disulfide bond was specifically reduced and blocked with iodoacetamide [Jullien, M., & Baldwin, R. L. (1981) J. Mol. Biol. 145, 265-280]. Since this effect is independent of the stability of the protein, it is consistent with a model in which the proper docking of the interior residues of the protein is the rate-limiting step in the folding of these mutants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693524     DOI: 10.1021/bi00470a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Toward development of a screen to identify randomly encoded, foldable sequences.

Authors:  Yoshihisa Hagihara; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

2.  Raman study of the thermal behaviour and conformational stability of basic pancreatic trypsin inhibitor.

Authors:  Pedro Carmona; Marina Molina; Arantxa Rodríguez-Casado
Journal:  Eur Biophys J       Date:  2003-01-30       Impact factor: 1.733

3.  Comparison of solution structures of mutant bovine pancreatic trypsin inhibitor proteins using two-dimensional nuclear magnetic resonance.

Authors:  M R Hurle; C D Eads; D A Pearlman; G L Seibel; J Thomason; P A Kosen; P Kollman; S Anderson; I D Kuntz
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

4.  Genetic dissection of pancreatic trypsin inhibitor.

Authors:  D P Goldenberg; J M Berger; D A Laheru; S Wooden; J X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Solvent Effects on the Energetics of Prolyl Peptide Bond Isomerization.

Authors:  Eric S Eberhardt; Stewart N Loh; Andrew P Hinck; Ronald T Raines
Journal:  J Am Chem Soc       Date:  1992       Impact factor: 15.419

6.  Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding.

Authors:  J K Myers; C N Pace; J M Scholtz
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

7.  High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli.

Authors:  M Jansson; Y C Li; L Jendeberg; S Anderson; G T Montelione; B Nilsson
Journal:  J Biomol NMR       Date:  1996-03       Impact factor: 2.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.